Two in Three Patients Hide Weight Loss Treatment, UK Study Finds
17.03.2026 - 23:29:26 | prnewswire.co.ukThe findings highlight the social barriers patients face. Thirty-eight percent report being judged for using GLP-1 treatment, nearly 80% have been accused of taking the "easy way out," and 68% were told to "eat less and move more." One in five patients (21%) say fear of social stigma influenced their decision to pursue treatment.
Younger adults are particularly affected, with concealment peaking at 74% among Gen Z, compared with 60% of Boomers and 43% of the Silent Generation. Women are also more likely to hide treatment than men (69% vs 53%). Paradoxically, the groups most open to treatment and most aware that obesity is a chronic medical condition are often those who feel most pressure to conceal it.
Despite public perception of GLP-1 as a shortcut, patient-reported outcomes tell a different story. 92% report improved overall health, along with gains in energy, mobility and confidence, and 88% say treatment has helped them sustain healthier lifestyle habits. On average, patients had attempted four other weight loss methods before starting medication, showing that treatment often follows years of effort, rather than replacing it.
The study underscores a critical gap between perception and reality. While GLP-1 therapies are clinically effective and deliver meaningful benefits, social stigma and outdated narratives may be limiting uptake and engagement. Aligning public understanding with medical evidence will be essential to improving access, adherence and long-term health outcomes.
Report available at: www.simpleonlinepharmacy.co.uk/research/stigma-survey
View original content:https://www.prnewswire.co.uk/news-releases/two-in-three-patients-hide-weight-loss-treatment-uk-study-finds-302702972.html
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Für. Immer. Kostenlos

